ANTITUMOR AGENTS

New antitumor agents (A) comprise: (1) a tublin-polymerization inhibitor (I) having antitumor activity; and (2) an antiinflammatory agent (II), optionally in combined use. An independent claim is also included for a method of treating tumors comprising administering (A) into the body. ACTIVITY : Cyt...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NIHEI, YUKIO, SUZUKI, MANABU, SUGA, YASUYO, MORINAGA, YOSHIHIRO
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	New antitumor agents (A) comprise: (1) a tublin-polymerization inhibitor (I) having antitumor activity; and (2) an antiinflammatory agent (II), optionally in combined use. An independent claim is also included for a method of treating tumors comprising administering (A) into the body. ACTIVITY : Cytostatic; Antiinflammatory; Immunosuppressive. The separate administration of (Z)-N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide hydrochloride and dexamethasone to malignant tumor-transplanted rats was performed and the antitumor effects was studied and ascertained. No further information given. MECHANISM OF ACTION : Tublin-Polymerization Inhibitor.